Cargando…

Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide

Patients with fulminant type 1 diabetes almost completely lack C-peptide even soon after the onset of the disease, and the deficiency continues for the rest of their life. Thus, fulminant type 1 diabetes could serve as a good model of nature to explore the physiological role of C-peptide. For exampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murase-Mishiba, Yuko, Imagawa, A., Hanafusa, Toshiaki
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323619/ https://www.ncbi.nlm.nih.gov/pubmed/18437231 http://dx.doi.org/10.1155/2008/819123

Ejemplares similares

“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018)

Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel α-Cell Model of Insulin-Deficient Diabetes
por: Bessho, Megumi, et al.
Publicado: (2014)

Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
por: Haseda, Fumitaka, et al.
Publicado: (2016)

Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010)

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies
por: Tsutsumi, Chiharu, et al.
Publicado: (2011)

Differences in the Contribution of the CTLA4 Gene to Susceptibility to Fulminant and Type 1A Diabetes in Japanese Patients
por: Kawasaki, Eiji, et al.
Publicado: (2008)

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)
por: Imagawa, Akihisa, et al.
Publicado: (2012)

Diagnostic criteria for acute‐onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus
por: Kawasaki, Eiji, et al.
Publicado: (2014)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic
por: Sano, Hiroyuki, et al.
Publicado: (2022)

Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral
por: Kusuki, Kazuhisa, et al.
Publicado: (2020)

Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level
por: Miyauchi, Masaaki, et al.
Publicado: (2019)

Fulminant type 1 diabetes mellitus in pregnancy
por: Li, Chun-Yu, et al.
Publicado: (2020)

Type 1 Diabetes and Interferon Therapy: A nationwide survey in Japan
por: Nakamura, Kan, et al.
Publicado: (2011)

Ketosis prone diabetes presenting as fulminant type 1 diabetes
por: krompa, Katerina, et al.
Publicado: (2018)

Immunological Aspects of Fulminant Type 1 Diabetes in Chinese
por: Wang, Zhen, et al.
Publicado: (2016)

Fatty liver formation in fulminant type 1 diabetes
por: Matsuo, Takashi, et al.
Publicado: (2016)

A Patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of Hyperglycemia
por: Yamamoto, Naoko, et al.
Publicado: (2019)

Association of HLA Genotype and Fulminant Type 1 Diabetes in Koreans
por: Kwak, Soo Heon, et al.
Publicado: (2015)

Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction
por: Yamada, Hodaka, et al.
Publicado: (2014)

Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes
por: Saheki, Takanobu, et al.
Publicado: (2019)

Fulminant type 1 diabetes mellitus: Two case reports
por: You, Wei, et al.
Publicado: (2019)

Glucagon secretions are impaired in patients with fulminant type 1 diabetes
por: Komada, Hisako, et al.
Publicado: (2019)

MON-126 Fulminant Type 1 Diabetes Caused by "Jumping"
por: Chen, Yaning, et al.
Publicado: (2019)

Integrative Analyses of Genes Associated with Fulminant Type 1 Diabetes
por: Ye, Xiaofeng, et al.
Publicado: (2020)

Fulminant type 1 diabetes after COVID-19 vaccination
por: Tang, Xiaohan, et al.
Publicado: (2022)

A Case of Fulminant Type 1 Diabetes in a Patient with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2017)

A case of fulminant type 1 diabetes and protein C deficiency complicated by deep vein thrombosis
por: Kohata, Masato, et al.
Publicado: (2023)

A case of fulminant type 1 diabetes masquerading acute pancreatitis
por: Matsuura, Naoki, et al.
Publicado: (2017)

High risk of renal dysfunction in patients with fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2017)

Fulminant Type 1 Diabetes in Children: A Multicenter Study in China
por: Gu, Yi, et al.
Publicado: (2017)

A Case of Fulminant Type 1 Diabetes with Gastric and Urinary Retention
por: Xing, Chuan, et al.
Publicado: (2018)

An Unusual Case of Fulminant Type 1 Diabetes Developed during Puerperium
por: Shihabudheen, P., et al.
Publicado: (2021)

Fulminant type 1 diabetes developed after influenza split vaccination
por: Sawamura, Toshitaka, et al.
Publicado: (2023)

Spontaneous pneumoperitoneum and diabetic ketoacidosis in fulminant type 1 diabetes: a case report
por: Sato, Motoya, et al.
Publicado: (2023)

Exploring C-peptide loss in type 1 diabetes using growth curve analysis
por: Besser, Rachel E. J., et al.
Publicado: (2018)

Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
por: Itoh, Naoto, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_4o1s2oith0e1iuqpk5809l4j0l